# US Pharmaceutical Manufacturing Equipment Market

> United States Pharmaceutical Manufacturing Equipment Market Research Report Information By Equipment Type (Packaging Machines, Mixing and Blending Machines, Inspection Equipment, Extrusion Equipment, Spray Drying Equipment, Milling Equipment, Tablet Compression Presses, and Filling Machines), By End-Product Type (Liquid and Solid) – United States Market Forecast Till 2035

- **Forecast Period:** 2025 - 2035
- **CAGR:** 3.21%
- **2024:** $ 15.75 Billion
- **2025:** $ 16.31 Billion
- **2035:** $ 22.3 Billion
- **Key Players:** Thermo Fisher Scientific (US), GE Healthcare(US), Sartorius AG (US), Parker Hannifin Corporation (US), Becton Dickinson and Company (US), Merck KGaA (US), Abbott Laboratories (US), Fujifilm Diosynth Biotechnologies (US), Eppendorf AG (US)

**Report ID:** MRFR/MED/20207-HCR · **Pages:** 128 · **Author:** Rahul Gotadki · **Last Updated:** April 06, 2026

**URL:** https://www.marketresearchfuture.com/reports/us-pharmaceutical-manufacturing-equipment-market-21805

---

## Market Summary

## **United States Pharmaceutical Manufacturing Equipment Market Overview**

United States Pharmaceutical Manufacturing Equipment Market Size was valued at USD 16.11 Billion in 2023. The Pharmaceutical Manufacturing Equipment market industry is projected to grow from USD 17.4 Billion in 2024 to USD 29.79 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 6.16% during the forecast period (2023 - 2032). The growing need for generics and a rising desire for pharmaceuticals are the main market drivers anticipated to propel the Pharmaceutical Manufacturing Equipment market in the United States.

Source: Secondary Research, Primary Research, _Market Research Future_ Database and Analyst Review

## **United States Pharmaceutical Manufacturing Equipment Market Trends**

### **Growing demand for lyophilizers is driving the market growth**

Perishable materials are preserved and dried in laboratory and pharmaceutical settings using lyophilizers, sometimes called freeze dryers. To get the frozen water in the substance to sublime, avoid the liquid phase, and transition straight from a solid to a gas, the process of lyophilization entails freezing the material and then placing it under an intense vacuum. This preserves the material and allows it to be kept dry and preserved for an extended time without becoming bad.

The United States market growth is anticipated to expand throughout the projected period due to factors including rising investment in the pharmaceutical industry and initiatives by major market players.

In addition, PCI Pharma Services committed USD 100 million in May 2022 to expand the capabilities and capacity of its production plant in Bedford for sterile lyophilization and aseptic liquid fill-finish technology. In May 2022, OPTIMA invested in a cutting-edge facility to expedite and safely integrate pharmaceutical lines into production. Optima Pharma is extending the efficacious CSPE procedure for the swift and secure initiation of production start-up of integrated filling lines with isolators and freeze dryers.

Throughout the projection period, there is likely a rise in investment in the United States for lyophilizers for the drug manufacturing process due to the growing acceptance of biopharmaceutical production equipment over time.

Furthermore, advanced robotics and automation technologies simplify manufacturing procedures, increasing production and efficiency. The total manufacturing time can be decreased by using these technologies to complete repetitive operations quickly and precisely. In the United States pharmaceutical production industry, automation and robotics lessen the need for manual labor for repetitive activities. This lowers labor costs and reduces the possibility of mistakes, guaranteeing consistent product quality. Modern automation systems are designed to be flexible and easily scalable. This allows pharmaceutical manufacturers to adapt to changing production demands, handle different formulations, and efficiently adjust production volumes as needed.

Thus, driving the United States Pharmaceutical Manufacturing Equipment market revenue.

## **United States Pharmaceutical Manufacturing Equipment Market Segment Insights**

### **Pharmaceutical Manufacturing Equipment Equipment Type Insights**

Based on equipment type, the United States Pharmaceutical Manufacturing Equipment market segmentation includes packaging machines, mixing and blending machines, inspection equipment, extrusion equipment, spray drying equipment, milling equipment, tablet compression presses, and filling machines. The packaging machines segment dominated the market mostly.

[Pharmacies](../../../reports/pharmacy-market-12003) can maintain product quality and compliance with labeling, dosing, and storage requirements by using pharmaceutical packaging machines to shield the finished product from contamination, deterioration, and damage. A drug product's ability to be used safely, effectively, and in compliance with regulations depends on how well and precisely it is packaged. Pharmaceutical packaging machines are becoming increasingly technologically advanced to comply with strict regulatory policies. This is due to the growing incidence of chronic diseases, the aging population, and rising healthcare spending. These factors are creating a demand for novel and diverse drugs.

The mixing and blending machines category are anticipated to be the fastest growing. Granulation is the process of combining small powder particles into bigger granules to minimize segregation and make the granules simpler to handle. Mixing and blending equipment is employed in wet and dry granulation operations to attain the intended particle size distribution and enhance the granules' flow characteristics.

### **Pharmaceutical Manufacturing Equipment End-Product Type Insights**

Based on end-product type, the United States Pharmaceutical Manufacturing Equipment market segmentation includes liquid and solid. The liquid category generated the most income. Patients with trouble swallowing pills or capsules may find liquid dose forms more comfortable. Since it is simple to quantify and modify the amount of medicine in each dose, they enable accurate dosing. This is especially crucial for medications that need to be taken precisely or have a limited therapeutic range. Intractable or unstable drugs in solid dosage forms can be synthesized as solutions or suspensions using liquid dosage forms, giving formulators more creative freedom.

These factors fuel the market for liquid dosage forms since people prefer them over solid ones.

The solid category is expected to have the quickest rate. Tablets and capsules are oral solid dosage forms that still rule the pharmaceutical industry. Because patients tend to like these forms, pharmaceutical companies invest in machinery capable of producing high-quality solid-dose products efficiently.

**Figure 1: United States Pharmaceutical Manufacturing Equipment Market, by End-Product Type, 2022 & 2032 (USD Billion)**

****

**Source: Secondary Research, Primary Research, MRFR Database and Analyst Review**

### **Pharmaceutical Manufacturing Equipment Country Insights**

During the evaluation period, the United States is anticipated to maintain its market share. The nation is expected to gain a 6.5% market share, according to the latest market projections. Growth in the pharmaceutical manufacturing equipment market is anticipated to be driven by the increased focus on new developments and improvements. As a developed nation, the United States is poised to spearhead market expansion. In addition, there should be profitable chances due to the area's expanding technical improvement. Because people's preferences are moving towards generic medications, the country's growing generic pharmaceutical business is predicted to generate considerable prospects.

## **United States Pharmaceutical Manufacturing Equipment Key Market Players & Competitive Insights**

The market for pharmaceutical manufacturing equipment is expected to grow even more due to major players in the industry making significant R&D investments to extend their lines of equipment. Alongside these significant market developments, market participants engage in various strategic actions to broaden their market reach. These activities include introducing new equipment types, contractual agreements, mergers and acquisitions, increased investments, and cooperation with other organizations. The pharmaceutical manufacturing equipment sector needs to provide affordable products to grow and thrive in a more cutthroat and dynamic market.

Major United States Pharmaceutical Manufacturing Equipment market players are attempting to increase market demand by investing in research and development operations, including Thermo Fisher Scientific Inc., Pall Corporation, Honeywell, Rockwell Automation, MilliporeSigma, GE Healthcare, and Emerson.

### **Key Companies in the United States Pharmaceutical Manufacturing Equipment market include**

- [Thermo Fisher Scientific Inc.](https://www.thermofisher.com/in/en/home/industrial/pharma-biopharma.html)
- Pall Corporation
- Honeywell
- Rockwell Automation
- MilliporeSigma
- GE Healthcare
- Emerson

## **United States Pharmaceutical Manufacturing Equipment Market Segmentation**

### **Pharmaceutical Manufacturing Equipment Equipment Type Outlook**

- Packaging Machines
- Mixing and Blending Machines
- Inspection Equipment
- Extrusion Equipment
- Spray Drying Equipment
- Milling Equipment
- Tablet Compression Presses
- Filling Machines

### **Pharmaceutical Manufacturing Equipment End-Product Type Outlook**

- Liquid
- Solid

## Market Drivers

### Increased Investment in R&D

The US Pharmaceutical Manufacturing Equipment Market is benefiting from increased investment in research and development (R&D) by pharmaceutical companies. In 2025, R&D spending in the US pharmaceutical sector is projected to exceed $100 billion, reflecting a commitment to innovation and the development of new therapies. This investment drives the need for advanced manufacturing equipment capable of supporting complex production processes and ensuring high-quality outputs. As companies strive to bring new drugs to market, the demand for specialized equipment that can accommodate diverse manufacturing needs is expected to rise. This trend underscores the critical role of R&D in shaping the future of the US Pharmaceutical Manufacturing Equipment Market.

### Growing Focus on Sustainability

The US Pharmaceutical Manufacturing Equipment Market is increasingly prioritizing sustainability as environmental concerns gain prominence. Pharmaceutical companies are under pressure to adopt eco-friendly practices, leading to a shift towards sustainable manufacturing processes. In 2025, it is anticipated that over 50% of pharmaceutical manufacturers in the US will implement green technologies in their operations. This shift not only addresses regulatory pressures but also aligns with consumer expectations for environmentally responsible practices. Consequently, the demand for equipment that supports sustainable manufacturing, such as energy-efficient systems and waste reduction technologies, is likely to grow. This focus on sustainability is expected to play a pivotal role in the evolution of the US Pharmaceutical Manufacturing Equipment Market.

### Rising Demand for Biopharmaceuticals

The US Pharmaceutical Manufacturing Equipment Market is experiencing a notable increase in demand for biopharmaceuticals, driven by advancements in biotechnology and personalized medicine. As of 2025, biopharmaceuticals accounted for approximately 40% of the total pharmaceutical market in the United States. This surge necessitates sophisticated manufacturing equipment capable of producing complex biologics, such as monoclonal antibodies and gene therapies. Consequently, manufacturers are investing in state-of-the-art equipment to enhance production efficiency and ensure compliance with stringent regulatory standards. The growing focus on biologics is likely to propel the demand for specialized equipment, thereby shaping the landscape of the US Pharmaceutical Manufacturing Equipment Market.

### Regulatory Compliance and Quality Standards

The US Pharmaceutical Manufacturing Equipment Market is significantly influenced by stringent regulatory requirements imposed by agencies such as the FDA. Compliance with Good Manufacturing Practices (GMP) is paramount, as it ensures the safety and efficacy of pharmaceutical products. In 2025, the FDA introduced new guidelines aimed at enhancing the quality of manufacturing processes, which has led to increased investments in advanced manufacturing technologies. Equipment that meets these evolving standards is in high demand, as companies seek to avoid costly penalties and product recalls. This regulatory landscape is expected to drive innovation and modernization within the US Pharmaceutical Manufacturing Equipment Market, as manufacturers strive to maintain compliance while optimizing production.

### Technological Advancements in Manufacturing Processes

The US Pharmaceutical Manufacturing Equipment Market is witnessing rapid technological advancements that are transforming traditional manufacturing processes. Innovations such as continuous manufacturing and process analytical technology (PAT) are gaining traction, allowing for more efficient and flexible production methods. In 2025, it is estimated that continuous manufacturing could reduce production costs by up to 30%, making it an attractive option for pharmaceutical companies. These advancements not only enhance productivity but also improve product quality and reduce time-to-market. As a result, the demand for cutting-edge manufacturing equipment that supports these technologies is likely to grow, further shaping the dynamics of the US Pharmaceutical Manufacturing Equipment Market.

## Future Outlook

The US Pharmaceutical Manufacturing Equipment Market is projected to grow at a 3.21% CAGR from 2025 to 2035, driven by technological advancements, regulatory changes, and increasing demand for biopharmaceuticals.

**New opportunities:**

- Integration of AI-driven predictive maintenance solutions Expansion of modular manufacturing systems for flexibility Development of advanced sterilization technologies for safety

By 2035, the market is expected to be robust, reflecting sustained growth and innovation.

## Segment Insights

### By Application: Tablet Manufacturing (Largest) vs. Liquid Manufacturing (Fastest-Growing)

The US Pharmaceutical Manufacturing Equipment Market is witnessing significant segmentation in applications, with tablet manufacturing holding the largest market share. This segment is propelled by the ongoing demand for solid dosage forms among pharmaceutical companies, which prefer tablets for their efficacy and ease of administration. In contrast, liquid manufacturing is rapidly emerging, contributing to the overall growth of the market as manufacturers increasingly shift towards flexible and customizable solutions to meet patient preferences and market demands.

Tablet Manufacturing (Dominant) vs. Liquid Manufacturing (Emerging)

Tablet manufacturing stands out as the dominant application within the US Pharmaceutical Manufacturing Equipment Market, driven by its established preference among pharmaceutical companies due to cost-effectiveness and stability in dosage forms. The technological advancements in tablet processing equipment and formulations are enhancing production efficiency and output quality. On the other hand, liquid manufacturing is swiftly emerging, largely due to the growing trend towards personalized medicine and biologics. This segment is characterized by the need for specialized equipment that can handle diverse formulation requirements while maintaining regulatory compliance, ultimately fostering innovation and flexibility in production practices.

### By End Use: Pharmaceutical Companies (Largest) vs. Contract Manufacturing Organizations (Fastest-Growing)

In the US Pharmaceutical Manufacturing Equipment Market, pharmaceutical companies hold the largest share, leveraging advanced technologies to enhance production efficiency and meet regulatory standards. These companies are pivotal in driving the demand for manufacturing equipment, as they invest heavily in automation and innovation to streamline operations and improve product quality. Contract Manufacturing Organizations (CMOs) have become increasingly significant in the market, catering to pharmaceutical companies' growing need for outsourced production capabilities, thus capturing a robust and expanding portion of the market share.

Pharmaceutical Companies (Dominant) vs. Biotechnology Firms (Emerging)

Pharmaceutical companies dominate the US Pharmaceutical Manufacturing Equipment Market by utilizing extensive resources to ensure compliance and state-of-the-art production methods. They are characterized by large-scale operations and established supply chains that support high-volume manufacturing. In contrast, biotechnology firms are considered emerging players. They focus on specialized products and innovative processes but often operate on a smaller scale compared to traditional pharmaceutical companies. However, biotechnology firms are rapidly gaining traction as advancements in biopharmaceuticals increase. Their agility in research and development, coupled with a focus on personalized medicine, positions them uniquely for future growth, making them a crucial component of the overall market landscape.

### By Equipment Type: Mixers (Largest) vs. Filling Machines (Fastest-Growing)

In the US Pharmaceutical Manufacturing Equipment Market, the equipment type segment is highly competitive, with a significant share attributed to mixers, which are critical for blending ingredients to create high-quality formulations. Following mixers, filling machines are also gaining traction, mainly due to the increasing demand for precision and efficiency in the packaging process. Granulators and labeling machines, though essential, contribute a smaller share, reflective of their niche applications within the market.

Mixers (Dominant) vs. Filling Machines (Emerging)

Mixers hold a dominant position within the US Pharmaceutical Manufacturing Equipment Market, known for their versatility and ability to ensure consistent product quality and efficiency. They are crucial in various processes, including blending powders and liquids, thus driving their extensive adoption across pharmaceutical firms. On the other hand, filling machines are emerging as a key focus, characterized by innovation and rapid adoption of technologies such as automation and precision filling mechanisms. This shift arises from stringent regulatory requirements and the need for higher throughput, making filling machines vital for streamlining production while maintaining compliance.

### By Technology: Continuous Processing (Largest) vs. Automation Technology (Fastest-Growing)

In the US Pharmaceutical Manufacturing Equipment Market, the Technology segment showcases diverse values with a significant market share distribution. Continuous Processing stands out as the largest segment, providing manufacturers with efficiencies and better product consistency. In contrast, Automation Technology is rapidly gaining traction, attracting investment and interest as companies aim to minimize human errors and enhance production speed.

Technology: Continuous Processing (Dominant) vs. Automation Technology (Emerging)

Continuous Processing is a dominant force in the US pharmaceutical landscape, allowing manufacturers to streamline operations and maintain high-quality standards through consistent production flows. On the other hand, Automation Technology is emerging quickly in the market due to the growing demand for digitalization and smart manufacturing solutions. As pharmaceutical companies seek to improve workflow efficiencies and reduce operational costs, Automation Technology, driven by advancements in AI and IoT, is helping to optimize every stage of the manufacturing process. This dual focus on Continuous Processing and Automation Technology signals a transformative shift within the sector, aligning with broader industry trends that emphasize innovation and efficiency.

## Competitive Benchmarking

The Pharmaceutical Manufacturing Equipment Market is characterized by a dynamic competitive landscape, driven by innovation, technological advancements, and increasing demand for efficient production processes. Key players such as Thermo Fisher Scientific (US), GE Healthcare (US), and Sartorius AG (Germany) are strategically positioned to leverage their extensive portfolios and expertise in bioprocessing and laboratory equipment. These companies focus on enhancing operational efficiencies through digital transformation and strategic partnerships, which collectively shape a competitive environment that is increasingly reliant on advanced technologies and integrated solutions.
In terms of business tactics, companies are localizing manufacturing to reduce lead times and optimize supply chains, which is particularly crucial in a market that is moderately fragmented. The competitive structure is influenced by the presence of both large multinational corporations and smaller specialized firms, creating a diverse ecosystem where collaboration and innovation are paramount. This fragmentation allows for niche players to thrive alongside industry giants, fostering a competitive atmosphere that encourages continuous improvement and adaptation.
In December 2025, Thermo Fisher Scientific (US) announced the launch of a new line of automated liquid handling systems designed to enhance throughput and accuracy in pharmaceutical manufacturing. This strategic move is significant as it aligns with the growing trend towards automation in the industry, enabling companies to streamline their processes and reduce human error, thereby increasing overall productivity.
In November 2025, GE Healthcare (US) expanded its partnership with a leading biopharmaceutical company to co-develop next-generation bioprocessing technologies. This collaboration is indicative of GE's commitment to innovation and positions the company to capitalize on the increasing demand for biopharmaceuticals, which require advanced manufacturing solutions. Such partnerships not only enhance product offerings but also strengthen market presence through shared expertise and resources.
In October 2025, Sartorius AG (Germany) acquired a small biotech firm specializing in single-use technologies, which is a strategic move aimed at bolstering its capabilities in the rapidly growing bioprocessing segment. This acquisition reflects a broader trend of consolidation within the market, as companies seek to enhance their technological capabilities and expand their product portfolios to meet evolving customer needs.
As of January 2026, current competitive trends in the Pharmaceutical Manufacturing Equipment Market include a pronounced shift towards digitalization, sustainability, and the integration of artificial intelligence (AI) in manufacturing processes. Strategic alliances are increasingly shaping the landscape, allowing companies to pool resources and expertise to drive innovation. Looking ahead, competitive differentiation is likely to evolve from traditional price-based competition to a focus on technological advancements, supply chain reliability, and sustainable practices, underscoring the importance of innovation in maintaining a competitive edge.

## Report Scope

| MARKET SIZE 2024 | 15.75(USD Billion) |
| --- | --- |
| MARKET SIZE 2025 | 16.31(USD Billion) |
| MARKET SIZE 2035 | 22.3(USD Billion) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 3.21% (2024 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| Market Forecast Period | 2025 - 2035 |
| Historical Data | 2019 - 2024 |
| Market Forecast Units | USD Billion |
| Key Companies Profiled | Thermo Fisher Scientific (US), GE Healthcare (US), Sartorius AG (US), Parker Hannifin Corporation (US), Becton Dickinson and Company (US), Merck KGaA (US), Abbott Laboratories (US), Fujifilm Diosynth Biotechnologies (US), Eppendorf AG (US) |
| Segments Covered | Application, End Use, Equipment Type, Technology |
| Key Market Opportunities | Integration of advanced automation technologies enhances efficiency in the US Pharmaceutical Manufacturing Equipment Market. |
| Key Market Dynamics | Technological advancements and regulatory changes drive innovation in the US Pharmaceutical Manufacturing Equipment Market. |
| Countries Covered | US |

## Frequently Asked Questions

**Q: What is the current valuation of the US Pharmaceutical Manufacturing Equipment Market?**
A: As of 2024, the market valuation was 15.75 USD Billion.

**Q: What is the projected market size for the US Pharmaceutical Manufacturing Equipment Market by 2035?**
A: The market is projected to reach 22.3 USD Billion by 2035.

**Q: What is the expected CAGR for the US Pharmaceutical Manufacturing Equipment Market during the forecast period 2025 - 2035?**
A: The expected CAGR for the market during this period is 3.21%.

**Q: Which segments are included in the US Pharmaceutical Manufacturing Equipment Market?**
A: The market includes segments such as Tablet Manufacturing, Liquid Manufacturing, Packaging, Quality Control, and Process Automation.

**Q: What are the projected valuations for the Tablet Manufacturing segment by 2035?**
A: The Tablet Manufacturing segment is projected to grow from 5.0 USD Billion to 7.0 USD Billion by 2035.

**Q: Who are the key players in the US Pharmaceutical Manufacturing Equipment Market?**
A: Key players include Thermo Fisher Scientific, GE Healthcare, Sartorius AG, and Becton Dickinson and Company.

**Q: What is the expected growth for the Automation Technology segment by 2035?**
A: The Automation Technology segment is expected to grow from 5.25 USD Billion to 7.8 USD Billion by 2035.

**Q: How does the market size for Contract Manufacturing Organizations compare to Pharmaceutical Companies?**
A: In 2024, the market size for Pharmaceutical Companies was 6.3 USD Billion, while Contract Manufacturing Organizations was 4.5 USD Billion.

**Q: What is the projected growth for Filling Machines in the US Pharmaceutical Manufacturing Equipment Market?**
A: Filling Machines are projected to grow from 4.0 USD Billion to 5.5 USD Billion by 2035.

**Q: What trends are influencing the US Pharmaceutical Manufacturing Equipment Market?**
A: Trends include advancements in automation technology and the increasing demand for single-use technology.


---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/us-pharmaceutical-manufacturing-equipment-market-21805*